HM

Hua Medicine

China - Shanghai
Biotechnology

Focus: Small Molecules

Hua Medicine is a life sciences company focused on Small Molecules.

Metabolic DiseasesRespiratoryNeurologyInfectious DiseasesOncology
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

China Headache and Vertigo Registry Study
Headache Disorders, Primary
N/A
Clinical Trials (1)
NCT04939922China Headache and Vertigo Registry Study
N/A
International Headache Registry Study
Headache Disorders, Primary
N/A
Clinical Trials (1)
NCT05418218International Headache Registry Study
N/A
Clinical Trials (1)
NCT04128280Multi-center Clinical Observation of a New Treatment Method Based on the Pathogenesis of Obstructive Prostatitis
N/A
traditional chinese medicine Xuanfei-Zhike formula
Cough Variant Asthma
N/A
Clinical Trials (1)
NCT05459805Multicenter Clinical Study on the Optimal Treatment Protocol and Outcome of Cough Variant Asthma With Chinese and Western Medicine
N/A
Super High-Pressure Non-Compliant Balloon
Vascular Calcification
N/A
Clinical Trials (1)
NCT07279987Comparison of RA-IVL and RA-SHP in Calcified Coronary Lesions
N/A
Total Laparoscopic or Robotic Radical Hysterectomy
Cervical Cancer
N/A
Clinical Trials (1)
NCT04934982Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IA1 With LVSI, IA2)
N/A
Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study
Adverse Drug Reaction
N/A
Clinical Trials (1)
NCT01946919Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study
N/A
Tianqi Pingchan Granule
Levodopa-Induced Dyskinesia
N/A
Clinical Trials (1)
NCT04173845Double Randomized and Placebo Controlled Trail of Tianqi Pingchan Granule to Prevent Levodopa-Induced Dyskinesia
N/A
CGRP R Inhibitor; CGRP Inhibitor
Vestibular Migraine
N/A
Clinical Trials (1)
NCT07203248Chinese Real-world Study of Treatment of Vestibular Migraine
N/A
Neurologic Manifestations of COVID-19
Coronavirus Disease 2019
N/A
Clinical Trials (1)
NCT04386083Neurologic Manifestations of COVID-19
N/A
urgent-start peritoneal dialysis catheter
End-Stage Renal Disease
N/A
Clinical Trials (1)
NCT02946528Urgent-start Peritoneal Dialysis in ESRD Patients:A Multi-center Study
N/A
Dorzagliatin
Drug Interaction
Phase 1
Clinical Trials (1)
NCT04080596DDI Study to Investigate the Impact of Itraconazole on the Pharmacokinetics of Dorzagliatin
Phase 1
Clinical Trials (1)
NCT02077452Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HMS5552 in Patients With Type 2 Diabetes
Phase 1
Phase 1
Clinical Trials (1)
NCT03158506Human Mass Balance Study of HMS5552 in Healthy Subjects
Phase 1
Clinical Trials (1)
NCT01952535A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral HMS5552 in Healthy Volunteers
Phase 1
Sitagliptin
Patients
Phase 1
Clinical Trials (1)
NCT03790839Drug Interaction Study Between Dorzagliatin and Sitagliptin
Phase 1
Clinical Trials (1)
NCT04426708A Clinical Study to Access the Pharmacokinetics of HMS5552 in Hepatic Impaired Subjects and Healthy Volunteers
Phase 1
Dorzagliatin
Drug Interaction
Phase 1
Clinical Trials (1)
NCT04080609DDI Study Between Dorzagliatin and Rifampicin
Phase 1
Empagliflozin
Patients
Phase 1
Clinical Trials (1)
NCT03790787Drug Interaction Study Between Dorzagliatin and Empagliflozin
Phase 1
Clinical Trials (1)
NCT04324424A Clinical Study to Access the Pharmacokinetics of HMS5552 in Renal Impaired Subjects and Healthy Volunteers
Phase 1
Phase 1
Clinical Trials (1)
NCT02597400Drug-Drug Interaction Study of Glucokinase Activator HMS5552 and Metformin in T2DM
Phase 1
Phase 1
Clinical Trials (1)
NCT02386982Beta Cell Function and Related Pharmacodynamics of HMS5552 in T2DM Patients
Phase 1
Phase 1
Clinical Trials (1)
NCT06498284Evaluate HM-002-1005 in Subjects With Type 2 Diabetes Mellitus
Phase 1
Clinical Trials (1)
NCT02561338A Multi-center 12-week Study of HMS5552 in T2DM
Phase 2
Clinical Trials (1)
NCT03141073Long-term Efficacy and Safety of HMS5552 add-on to Metformin in T2DM Subjects
Phase 3
Clinical Trials (1)
NCT03173391Long-term Efficacy and Safety of HMS5552 in T2DM Subjects
Phase 3
Recombinant Human Growth Hormone Injection
Dwarfism
Phase 3
Clinical Trials (1)
NCT03535415A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before Transplantation
Phase 3
Dorzagliatin tablets
Type2diabetes
Phase 4
Clinical Trials (1)
NCT06263348A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes
Phase 4
Phase 4
Clinical Trials (1)
NCT01788371Nucleoside Analogue Prevent Vertical Transmission of Hepatitis B Virus
Phase 4

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 29 clinical trials
Top TAs: Metabolic Diseases, Neurology, Infectious Diseases
Publications: 25 in PubMed
Therapeutic Area Focus
Neurology
4 pipeline
Nephrology
1 pipeline
Oncology
1 pipeline
Respiratory
1 pipeline
Marketed
Pipeline